Perilla Oil

Perilla Oil is a fatty-acid active commonly considered for cardio, cognitive and skin ranges, sitting in the botanicals family. On DAT Supply briefs the positioning is set by the brand brief and reviewed against the target market’s claim rules — we do not pre-position an active for any single benefit. Editorial framing uses only EU 432/2012- or DSHEA-compatible wording — we never promote unauthorised claims, even when the active has consumer-side momentum. Format-wise we have considered Perilla Oil for gummies; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — no two briefs land on the same combination, and we don’t publish off-the-shelf doses.

• Gummies

How we use Perilla Oil in formulas

A public-safe formulation reference — how this active behaves in our formats, common pairings and handling notes. Final formulation, dose and on-pack copy are confirmed per project.

Heat stable

Limited — use coated forms

Soluble in matrix

Conditional

Vegan supply

Project-specific

As a fatty-acid active Perilla Oil is reviewed against the EU 432/2012 authorised list (e.g. EPA / DHA wording for heart and brain), with UK wording tracking EU post-Brexit. For the US market, label benefit copy follows DSHEA structure-function rules with the FDA disclosure. Source form (triglyceride, ethyl-ester, phospholipid) and oxidation profile are reviewed against the format’s stability window — confirmed per project. Where the active is sensitive to heat or oxygen, the format selection is biased toward softgel, oral liquid or shot-vial routes, and the antioxidant load is tuned against the shelf-life target.

Perilla Oil is measured by weight (mg) per serving on DAT Supply briefs. The working anchor — the inclusion rate against which target-market claim wording is reviewed — is set during the formulation pass for each project rather than published as a fixed number on the public page. Final per-serving load depends on the chosen format (gummy payload window, capsule fill weight, softgel oil load, sachet or powder scoop size, oral-liquid bottle geometry) and the claim wording the brand needs to support against the target market. Sourcing form (extract ratio, standardised marker, micronised vs granular, salt or chelate form) is reviewed in the same pass. Country-level upper limits (France, Italy, Belgium for the EU; California Prop 65 for the US) are checked before any inclusion rate is finalised. Dose is confirmed per project — we don’t publish off-the-shelf dose tables for any active in the catalogue.

The formulas above sit in this private-label range: